BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22963596)

  • 1. Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid.
    Shimizu A; Funakoshi T; Ishibashi M; Yoshida T; Koga H; Hashimoto T; Amagai M; Ishiko A
    Br J Dermatol; 2013 Mar; 168(3):647-55. PubMed ID: 22963596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA anti-p200 pemphigoid.
    Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
    Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of anti-p200 pemphigoid.
    Rose C; Weyers W; Denisjuk N; Hillen U; Zillikens D; Shimanovich I
    Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human skin basement membrane in health and in autoimmune diseases.
    Chan LS
    Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
    Iwata H; Kitajima Y
    Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The site of blister formation in dermatitis herpetiformis is within the lamina lucida.
    Smith JB; Taylor TB; Zone JJ
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):209-13. PubMed ID: 1430358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
    Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
    J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized bullous pemphigoid: report of a case with an immunofluorescence and electron microscopical studies on the lesional distribution of 180-KD bullous pemphigoid antigen, beta 4 integrin, and type VII collagen.
    Kitajima Y; Suzuki M; Johkura Y; Yaoita H
    J Dermatol; 1993 Jul; 20(7):406-12. PubMed ID: 8408921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's new in bullous pemphigoid.
    Ujiie H; Shibaki A; Nishie W; Shimizu H
    J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
    Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
    Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of autoimmune bullous dermatosis with features of pemphigus vulgaris and bullous pemphigoid.
    Kore-eda S; Horiguchi Y; Ohtoshi E; Tanaka T; Fujii K; Okamoto H; Ikai K; Imamura S
    Am J Dermatopathol; 1995 Oct; 17(5):511-6. PubMed ID: 8599459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
    Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
    PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
    Gammon WR; Robinson T; Briggaman RA; Wheeler CE
    J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
    Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
    J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
    Toosi S; Bystryn JC
    Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.